Doctoral Degree
Joined the Communist Party of China during university in 1996. Place of Birth: Beijing; Place of Origin: Wuxi, Jiangsu Province.
Chief Physician, Associate Professor, Master's Supervisor, Third Ward of the Gastrointestinal Center, Peking University Cancer Hospital
Administrative Positions:
Deputy Director (Deputy Division-Level), Yunnan Hospital of Peking University Cancer Hospital, since February 2023; Member of the Party Committee and Deputy Director, Yunnan Hospital of Peking University Cancer Hospital, since February 2024.
Professional Expertise:
Colorectal Tumor Surgery
Academic Appointments:
Member, 7th and 8th Committees, Colorectal Cancer Professional Committee, Chinese Anti-Cancer Association
Second Council Member, Beijing Cancer Prevention and Treatment Society
Second Standing Committee Member, Beijing Cancer Society
Sixth Youth Editorial Board Member, *Chinese Journal of General Surgery*
Awards and Honors:
2006: Outstanding Communist Party Member in Earthquake Relief, Peking University
2018: Model Outstanding Communist Party Member, Peking University
Ongoing Research Projects:
Wu Jieping Medical Foundation: Molecular Mechanisms of Protease Inhibitors Interfering with Genomic DNA Methylation Modification in Colon Cancer (150,000 RMB)
Recent Publications:
1. Int J Biol Markers. 2021 Mar;36(1):47-53. doi: 10.1177/1724600820986572. Epub 2021 Feb 14. Low levels of BRCA1 protein expression predict a worse prognosis in stage I-II colon cancer. Changzheng Du, Yifan Peng, Yiping He, Guoan Chen, Hao Chen.
2. BMC Gastroenterol. 2024 Jul 11;24(1):222. doi: 10.1186/s12876-024-03317-5. The expression and clinical significance of CFAP65 in colon cancer. Yunze Li, Dongmei Ran, Shiva Basnet, Buzhe Zhang, Hongjing Pei, Chenchen Dan, Zixuan Zhang, Liang Zhang, Tianyu Lu, Yifan Peng, Changzheng Du.
3. Oncol Lett. 2023 May 10;25(6):272. doi: 10.3892/ol.2023.13858. eCollection 2023 Jun. Association between Ki67 expression and therapeutic outcome in colon cancer. Qi Liu, Dongmei Ran, Liping Wang, Jiajun Feng, Wei Deng, Dongdong Mei, Yifan Peng, Changzheng Du.
4. BMC Cancer. 2025 Apr 23;25(1):760. doi: 10.1186/s12885-025-14161-5. The expression of PRMT5 is associated with postoperative chemotherapeutic outcome in colon cancer. Lu Lu, Huan Li, Hongfang Yin, Feng Wang, Xiaowen Sun, Yanyun Chang, Yuling Sheng, Qi Liu, Yifan Peng, Changzheng Du.
English
